Alternative Cancer, Clinical Use

Improved microplate fluorometer counting of viable tumor and normal cells.

Anticancer Res. 1994 May-Jun;14(3A):927-31.

Riordan HD, Riordan NH, Meng X, Zhong J, Jackson JA.

Abstract

An improved method has been developed to count cells in situ based on the measurement of esterase activity with carboxyfluorescein diacetate. This sensitive, semiautomated microplate fluorometer assay was able to estimate viable cell numbers over a range of 5 X 102 to 2.6 XI@ cellslwell in a tumor cell line. Sensitiviiy to lo3 was demonstrated in two other cell lines. Sub- and supranormal fluorescence events which can be responsible for unreliable readings when using a fluorescence assay for cell counting were quantified in a menadione (cytotoxic agent)lU-87 MG (cell line) model. There was a close correlation between the fluorometer method and Coulter counter method for two different tumor cell lines when this method was pegormed on cells after sub- and supranormalfluorescence events had ceased.

link to full text

Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics.

Alternative Cancer

Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.

Alternative Cancer, Clinical Use, Vitamin C

The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary.

Alternative Cancer, Clinical Use

Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.

Alternative Cancer, Clinical Use, Vitamin C

Inhibition of human breast carcinoma cell proliferation by ascorbate and copper.

Alternative Cancer, Clinical Use, Vitamin C

Orthomolecular oncology: a mechanistic view of intravenous ascorbate’s chemotherapeutic activity.

Alternative Cancer, Vitamin C

Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis.

Alternative Cancer, Clinical Use, Supplements

Intravenous ascorbic acid: protocol for its application and use.

Alternative Cancer, Clinical Use, Vitamin C

L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.

Alternative Cancer, Clinical Use, Vitamin C

Cell membrane fatty acid composition differs between normal and malignant cell lines.

Alternative Cancer

Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.

Alternative Cancer, Clinical Use, Vitamin C

Orthomolecular oncology review: ascorbic acid and cancer 25 years later.

Alternative Cancer, Clinical Use, Vitamin C

Cancer is a functional repair tissue.

Alternative Cancer

A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.

Alternative Cancer, Clinical Use, Vitamin C

Induction of antitumor immunity through xenoplacental immunization.

Alternative Cancer

Safety of targeting tumor endothelial cell antigens.

Alternative Cancer, Umbilical Cord

Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer.

Alternative Cancer, Clinical Use, Vitamin C

Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.

Alternative Cancer, Clinical Use, Vitamin C

Exosomes as a tumor immune escape mechanism: possible therapeutic implications.

Alternative Cancer, Clinical Use

Granulocyte activity in patients with cancer and healthy subjects.

Alternative Cancer

Anti-angiogenic effect of high doses of ascorbic acid.

Alternative Cancer, Clinical Use, Vitamin C

Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo.

Adipose (Fat), Alternative Cancer, Vitamin C

Tumor vaccines in 2010: need for integration.

Alternative Cancer, Clinical Use

Immunotherapy for melanoma: current status and perspectives.

Alternative Cancer, Clinical Use

On the missing link between inflammation and cancer.

Alternative Cancer

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Alternative Cancer, Clinical Use

The bio-energetic theory of carcinogenesis.

Alternative Cancer

Schedule Dependence in Cancer Therapy: Intravenous Vitamin C and the Systemic Saturation Hypothesis.

Alternative Cancer, Vitamin C

Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.

Alternative Cancer, Clinical Use

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.

Alternative Cancer, Clinical Use, Vitamin C